OctoDEX^® is one of OctoPlus’ proprietary delivery systems for the controlled release of therapeutic proteins

The technology is based on crosslinked dextran microspheres, prepared without organic solvents. OctoDEX™ -based products can be used for both subcutaneous and intramuscular administration.

Key attributes of the OctoDEX^® drug delivery system are:

• Suited to encapsulate molecules of more than 10kD and small particles
• Release profiles customizable from zero-order to delayed pulse
• Excellent in vitro – in vivo correlation
• An all-aqueous encapsulation process, preserving the structural integrity of proteins
• Cost-effective, robust and easy upscalable process
• Successfully tested in humans
• Patent protected

Partner with OctoPlus for drug delivery with OctoDEX^®
OctoPlus is actively pursuing new partnerships to develop products based on the OctoDEX^® delivery system. As a medium sized organisation, we are flexible in constructing partnership agreements and are open to take on some of the risk and cost for the development of promising compounds. Our priority is to build successful long-term drug delivery partnerships. Please feel free to contact us and discuss your ideas.

For more information on the OctoDEX^® drug delivery technology, please download our OctoDEX^® factsheet.